BIO-RAD LABORATORIES -CL B (BIO.B) Stock Analyst Ratings
NYSE:BIO.B - New York Stock Exchange, Inc. - US0905721082 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 76% to BIO.B. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 369.39. This target is 57.58% above the current price.
BIO.B was analyzed by 11 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about BIO.B.
In the previous month the buy percentage consensus was at a similar level.
BIO.B was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-07-30 | Wells Fargo | Maintains | Overweight |
| 2021-02-12 | Citigroup | Maintains | Buy |